AAAAAA
Results: 1-25/48
Authors:
Pearce, RKB
Heikkila, M
Linden, IB
Jenner, P
Citation: Rkb. Pearce et al., L-dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations, PSYCHOPHAR, 156(4), 2001, pp. 402-409
Authors:
McNaught, KSP
Olanow, CW
Halliwell, B
Isacson, O
Jenner, P
Citation: Ksp. Mcnaught et al., Failure of the ubiquitin-proteasome system in Parkinson's disease, NAT REV NEU, 2(8), 2001, pp. 589-594
Authors:
Ferger, B
Rose, S
Jenner, A
Halliwell, B
Jenner, P
Citation: B. Ferger et al., 6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum, NEUROREPORT, 12(6), 2001, pp. 1155-1159
Authors:
Whitehead, KJ
Rose, S
Jenner, P
Citation: Kj. Whitehead et al., Involvement of intrinsic cholinergic and GABAergic innervation in the effect of NMDA on striatal dopamine efflux and metabolism as assessed by microdialysis studies in freely moving rats, EUR J NEURO, 14(5), 2001, pp. 851-860
Authors:
Iravani, MM
Costa, S
Jackson, MJ
Tel, BC
Cannizzaro, C
Pearce, RKB
Jenner, P
Citation: Mm. Iravani et al., GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets, EUR J NEURO, 13(3), 2001, pp. 597-608
Authors:
Treseder, SA
Rose, S
Jenner, P
Citation: Sa. Treseder et al., The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats, EUR J NEURO, 13(1), 2001, pp. 162-170
Authors:
Maratos, EC
Jackson, MJ
Pearce, RKB
Jenner, P
Citation: Ec. Maratos et al., Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus), MOVEMENT D, 16(4), 2001, pp. 631-641
Authors:
Medhurst, AD
Zeng, BY
Charles, KJ
Gray, J
Reavill, C
Hunter, AJ
Shale, JA
Jenner, P
Citation: Ad. Medhurst et al., Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-dopa treatment, NEUROSCIENC, 105(2), 2001, pp. 353-364
Authors:
McNaught, KSP
Jenner, P
Citation: Ksp. Mcnaught et P. Jenner, Proteasomal function is impaired in substantia nigra in Parkinson's disease, NEUROSCI L, 297(3), 2001, pp. 191-194
Authors:
Zeng, BY
Pearce, RKB
MacKenzie, GM
Jenner, P
Citation: By. Zeng et al., Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study, J NEURAL TR, 108(8-9), 2001, pp. 925-941
Authors:
Hurley, MJ
Mash, DC
Jenner, P
Citation: Mj. Hurley et al., Dopamine D-1 receptor expression in human basal ganglia and changes in Parkinson's disease, MOL BRAIN R, 87(2), 2001, pp. 271-279
Authors:
Jenner, P
Citation: P. Jenner, Parkinson's disease, pesticides and mitochondrial dysfunction, TRENDS NEUR, 24(5), 2001, pp. 245-246
Authors:
Ferger, B
Themann, C
Rose, S
Halliwell, B
Jenner, P
Citation: B. Ferger et al., 6-Hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation, J NEUROCHEM, 78(3), 2001, pp. 509-514
Authors:
Lee, M
Hyun, DH
Halliwell, B
Jenner, P
Citation: M. Lee et al., Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2, J NEUROCHEM, 78(2), 2001, pp. 209-220
Authors:
Lee, MH
Hyun, DH
Jenner, P
Halliwell, B
Citation: Mh. Lee et al., Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production, J NEUROCHEM, 78(1), 2001, pp. 32-41
Authors:
Lee, M
Hyun, DH
Jenner, P
Halliwell, B
Citation: M. Lee et al., Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis, J NEUROCHEM, 76(4), 2001, pp. 957-965
Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult
Authors:
Lee, M
Hyun, DH
Halliwell, B
Jenner, P
Citation: M. Lee et al., Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult, J NEUROCHEM, 76(4), 2001, pp. 998-1009
Authors:
Costa, S
Iravani, MM
Pearce, RKB
Jenner, P
Citation: S. Costa et al., Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets, EUR J PHARM, 412(1), 2001, pp. 45-50
Authors:
Zeng, BY
Pearce, RKB
MacKenzie, GM
Jenner, P
Citation: By. Zeng et al., Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA, EUR J NEURO, 12(3), 2000, pp. 1096-1104
Authors:
Riedl, AG
Watts, PM
Douek, DC
Edwards, RJ
Boobis, AR
Rose, S
Jenner, P
Citation: Ag. Riedl et al., Expression and distribution of CYP2C enzymes in rat basal ganglia, SYNAPSE, 38(4), 2000, pp. 392-402
Authors:
Treseder, SA
Smith, LA
Jenner, P
Citation: Sa. Treseder et al., Endogenous dopaminergic tone and dopamine agonist action, MOVEMENT D, 15(5), 2000, pp. 804-812
Authors:
Olanow, CW
Obeso, J
Jenner, P
Citation: Cw. Olanow et al., Levodopa-induced dyskinesias - Foreword, ANN NEUROL, 47(4), 2000, pp. S1-S1
Authors:
Jenner, P
Citation: P. Jenner, Factors influencing the onset and persistence of dyskinesia in MPTP-treated primates, ANN NEUROL, 47(4), 2000, pp. S90-S104
Authors:
Smith, LA
Jackson, MG
Bonhomme, C
Chezaubernard, C
Pearce, RKB
Jenner, P
Citation: La. Smith et al., Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset, CLIN NEUROP, 23(3), 2000, pp. 133-142
Authors:
Jenner, P
Citation: P. Jenner, Pathophysiology and biochemistry of dyskinesia: clues for the development of non-dopaminergic treatments, J NEUROL, 247, 2000, pp. 43-50